Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 251.00
Bid: 250.50
Ask: 252.00
Change: 1.00 (0.40%)
Spread: 1.50 (0.599%)
Open: 252.00
High: 252.00
Low: 248.00
Prev. Close: 250.00
CSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Apr 2019 07:00

RNS Number : 4559X
Chesnara PLC
30 April 2019
 

Chesnara plc

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility ('PDMRs')

 

Chesnara plc (the 'Company') today announces that, on 29 April 2019, John Deane and David Rimmington (each a PDMR) were granted awards of options over the ordinary shares of the Company under the Chesnara plc Long Term and Short Term Schemes. These awards were made in accordance with the Directors' Remuneration Policy.

 

The notifications for each PDMR below, which are being made in accordance with the requirements of the EU Market Abuse Regulations, provide further detail of the awards granted to each PDMR.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

John Deane

2

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2014 Short-term Incentive Scheme. The award is not subject to a performance target.

 

The options will become exercisable on 28 April 2022 and remain exercisable up to and including 27 April 2029.

 

GRANT 2

Granted under the Chesnara 2014 Long-term Incentive Scheme. The award is subject to a performance target over a period of three financial years.

 

Subject to the achievement of the performance target, the options will become exercisable on 28 April 2022 and remain exercisable up to and including 27 April 2029.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

13,323 options over ordinary shares of 5p each

Nil

GRANT 2

125,180 options over ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 138,503 options over ordinary shares of 5p each

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2019-04-29

f)

Place of the transaction

XOFF

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

David Rimmington

2

Reason for the notification

a)

Position/status:

Chief Finance Officer

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2014 Short-term Incentive Scheme. The award is not subject to a performance target.

 

The options will become exercisable on 28 April 2022 and remain exercisable up to and including 27 April 2029.

 

GRANT 2

Granted under the Chesnara 2014 Long-term Incentive Scheme. The award is subject to a performance target over a period of three financial years.

 

Subject to the achievement of the performance target, the options will become exercisable on 28 April 2022 and remain exercisable up to and including 27 April 2029.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

7,760 options over ordinary shares of 5p each

Nil

GRANT 2

71,070 options over ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 78,830 options over ordinary shares of 5p each

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2019-04-29

f)

Place of the transaction

XOFF

 

Name of authorised official of issuer responsible for making notification

Al Lonie

 

Date of notification 30 April 2019

 

 

 

 

Notes to Editors

 

Chesnara plc ('Chesnara'), which listed on the London Stock Exchange in May 2004, is the owner of Countrywide Assured plc ('CA plc'), Movestic Livförsäkringar AB ('Movestic') and Chesnara Holdings BV. Chesnara Holdings BV is the intermediate holding company of 'Waard Group' and 'Scildon'.

 

CA plc is a UK life assurance subsidiary that is closed to new business. In June 2005 Chesnara acquired a further closed life insurance company - City of Westminster Assurance - for £47.8m. With effect from 30 June 2006, CWA's policies and assets were transferred into CA plc. Save & Prosper Insurance Limited and its subsidiary, Save & Prosper Pensions Limited, were acquired on 20 December 2010 for £63.5 million. With effect from 31 December 2011, the business of Save & Prosper was transferred into CA plc. On 28 November 2013 Chesnara acquired Direct Line Life Insurance Company Limited (subsequently renamed Protection Life Company Limited) from Direct Line Group plc for £39.3m. On 31 December 2014 the PL business transferred into CA plc. CA plc operates an outsourced business model.

 

Movestic, a Swedish life assurance company which originally focused on pensions and savings, was acquired on 23 July 2009 for £20 million. The company is open to new business and seeks to grow its position in the Swedish unit-linked market. Its proposition was strengthened in February 2010 with the acquisition of the operations of Aspis Försäkringar Liv AB which has a risk and health product bias.

 

The Waard Group, a Netherlands-based Group comprising two closed book insurance companies (life and income protection) and a servicing company, was acquired on 19 May 2015 for €69.9m from DSB Beheer B.V., a Dutch financial services Group. The group comprises Waard Leven N.V., Waard Schade N.V. and Waard Verzekeringen B.V. The portfolio of the Waard Group is predominantly term life policies with some unit linked and income protection policies. On 5 April 2017 Chesnara completed its acquisition of Legal & General Nederland Levensverzeikering Maatschappij N.V. ('LGN') for €161.2 million. The business was renamed Scildon, is in the Dutch life assurance market and, as with our Swedish subsidiary Movestic, it writes protection and pension new business.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPGUCWCUPBGAB
Date   Source Headline
5th Jul 20187:00 amRNSHolding(s) in Company
21st May 20185:16 pmRNSPDMR and Total Voting Rights
16th May 20183:58 pmRNSResults of AGM
1st May 20187:00 amRNSDirector/PDMR Shareholding
24th Apr 20187:00 amRNSChesnara plc - Application for Block Listing
17th Apr 20187:00 amRNSNotice of AGM and Annual Report & Accounts
29th Mar 20187:00 amRNSFinal Results
15th Mar 20187:00 amRNSNotice of Results
14th Mar 201810:47 amRNSHolding(s) in Company
8th Mar 201810:13 amRNSHolding(s) in Company
5th Mar 20182:29 pmRNSExternal Chair appointment for Mike Evans
12th Jan 20183:05 pmRNSHolding(s) in Company
6th Dec 201710:21 amRNSTotal Voting Rights
4th Dec 20172:39 pmRNSHolding(s) in Company
24th Nov 201710:08 amRNSDirector/PDMR Shareholding
24th Nov 20177:00 amRNSCapital Markets Day
23rd Nov 20177:30 amRNSHolding(s) in Company
23rd Nov 20177:00 amRNSResult of External Audit Tender
7th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20174:06 pmRNSTotal Voting Rights
7th Sep 20177:34 amRNSStatement re: the Legacy Review
31st Aug 20177:00 amRNSHalf-year Report
17th Aug 20174:00 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSNotice of Results
2nd Aug 20177:00 amRNSTotal Voting Rights
18th May 20177:00 amRNSResult of AGM
28th Apr 20173:26 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSAnnual Financial Report & AGM Notice
11th Apr 20172:06 pmRNSSCILDON - new name for Legal & General Nederland
6th Apr 20177:00 amRNSCompletion of LGN acquisition
31st Mar 20177:00 amRNSFinal Results
30th Mar 20175:15 pmRNSAcquisition
6th Mar 201712:11 pmRNSNotice of Results
6th Jan 20177:00 amRNSHolding(s) in Company
19th Dec 20167:00 amRNSHolding(s) in Company
16th Dec 20164:56 pmRNSUpdate on Excess Applications
16th Dec 20162:15 pmRNSHolding(s) in Company
15th Dec 20168:00 amRNSAdmission of Shares
14th Dec 20167:00 amRNSDirectorate Change
13th Dec 20164:20 pmRNS2016 EGM Results, TVR and Director Dealing
13th Dec 20167:00 amRNSResults of Placing and Open Offer
24th Nov 20165:25 pmRNSPublication of a Prospectus
24th Nov 20167:01 amRNSProposed Acquisition and Placing
22nd Nov 20167:10 amRNSStatement regarding market speculation
22nd Nov 20167:00 amRNSStatement regarding press speculation
26th Oct 20167:00 amRNSDirectorate Change
29th Sep 201610:07 amRNSHolding(s) in Company
31st Aug 20167:00 amRNSHalf-year Report
30th Aug 20167:00 amRNSHolding(s) in Company
10th Aug 201612:17 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.